Header Logo

Connection

Christopher Hemond to Epstein-Barr Virus Nuclear Antigens

Back to Details
This is a "connection" page, showing publications Christopher Hemond has written about Epstein-Barr Virus Nuclear Antigens.
Christopher Hemond
Connection Strength
0.226
Epstein-Barr Virus Nuclear Antigens
  1. Bose A, Khalighinejad F, Hoaglin DC, Hemond CC. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review. Mult Scler Relat Disord. 2024 Apr; 84:105410.
    View in: PubMed
    Score: 0.226
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.